The Effect on Glycemic Responses and Subjective Ratings of Satiety of a Snack With or Without Ingredients to Slow Carbohydrate Digestion

September 25, 2018 updated by: PepsiCo Global R&D

Randomized, Controlled, Cross-over Study Comparing The Effect on Glycemic Responses and Subjective Ratings of Satiety of a Snack With or Without Ingredients to Slow Carbohydrate Digestion

The objective of this trial is to compare a snack with ingredients (whole grains and dietary fiber) to slow carbohydrate digestion to a similar control snack without such ingredients and evaluate the effect of the snack on glycemic response and subjective satiety. The test product will be compared with a control product as well as white bread in a randomized, controlled, crossover trial including 20 healthy males or females between the ages of 18 and 70 and having a body mass index (BMI) between 25 and 30 kg/m2. Following an overnight fast, participants will be given each of the study products in a random order at least a week apart. Glucose and insulin will be measured before product consumption and over a period of four hours. Visual analog scales to measure subjective satiety will also be administered over a period of four hours.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Healthy males or females between the ages of 18 and 70 inclusive
  2. No chronic medications other than oral contraceptives
  3. Body Mass Index (BMI) between 25 and 30 kg/m2 inclusive.
  4. Body weight stable in a 5 kg range in the 3 months prior to study entry

Exclusion Criteria:

  1. Pregnant or nursing a baby
  2. Women with child-bearing potential who are unwilling to use an effective means of contraception during the study which could include abstinence.
  3. Adults unable to consent and prisoners

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Test-cluster
56g of optimized savory cluster made through a proprietary process with slowly digestible carbohydrates and fiber
Test cluster is an optimized savory cluster made through a proprietary baking process combined with slow digestible carbohydrates and fiber
Placebo Comparator: Control-cluster
56g of control cluster made from general baking process with typical ingredients commonly used in commercially available energy snacks or bars
Test cluster is an optimized savory cluster made through a proprietary baking process combined with slow digestible carbohydrates and fiber
Placebo Comparator: White-bread
45g of white bread containing equivalent amount of available carbohydrate in 56g of optimized savory cluster
Test cluster is an optimized savory cluster made through a proprietary baking process combined with slow digestible carbohydrates and fiber

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
area under the curve (AUC) for glucose and insulin
Time Frame: 0-4 hours post consumption
0-4 hours post consumption

Secondary Outcome Measures

Outcome Measure
Time Frame
AUC for the visual analog scale (VAS) ratings of satiety
Time Frame: 0-4 hours post consumption
0-4 hours post consumption

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Frank Greenway, MD, Pennington Biomedical Research Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2015

Primary Completion (Actual)

February 1, 2016

Study Completion (Actual)

April 1, 2016

Study Registration Dates

First Submitted

February 17, 2016

First Submitted That Met QC Criteria

February 17, 2016

First Posted (Estimate)

February 23, 2016

Study Record Updates

Last Update Posted (Actual)

September 27, 2018

Last Update Submitted That Met QC Criteria

September 25, 2018

Last Verified

September 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • PEP-1512

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Glycemic Response; Satiety

Clinical Trials on Nutrient cluster

Subscribe